A Common-Sense Transparency Reform
The Trump administration has taken an important first step in tackling healthcare fraud, waste, and abuse: The 340B rebate model pilot.
The rebate model pilot introduces accountability by tying program discounts to verified, eligible use. Under this approach:
Hospitals and clinics would submit claims-level data to confirm eligibility
Discounts would be delivered as rebates — issued only after verification that the prescription was eligible for 340B, rather than provided upfront
Policymakers and the public would gain real visibility into how an $100+ billion program is being utilized
This is not a cut or a rollback. It is a common-sense transparency reform designed to restore integrity to a program that has long operated without it.
Why Reform Matters
- Patients still face high out-of-pocket costs at the pharmacy, even when hospitals acquire their medications at deeply discounted prices
- Employers and working families shoulder rising healthcare costs as 340B-driven markups inflate overall spending
- Taxpayers absorb mounting inefficiencies and overpay for medicines, with billions in lost revenue and little evidence of meaningful patient benefit
340B should function as a true safety net — not as a revenue stream for hospitals and middlemen.
Who Is Blocking Reform — and Why
The Trump administration’s rebate model pilot is facing organized opposition from hospital lobbying groups and their allies in Congress. Dozens of lawmakers are now pushing to block funding for the pilot.
Why the resistance? Because the current system is enormously profitable. Under the status quo, hospitals and their pharmacy partners can:
- Keep the full spread between discounted purchase prices and inflated billing rates
- Expand 340B operations into higher-revenue patient populations with no scrutiny
- Operate with no reporting requirements on how program profits are utilized
Transparency will bring new scrutiny to this program — and hospital lobbyists know it. When hospitals fight the rebate model pilot in court and work to kill it in Congress before it is even implemented, they are not protecting patients. They are protecting a revenue stream. Lawmakers should not do their bidding.
Let the Hospital Transparency Reform Move Forward
The Trump administration’s 340B rebate model pilot is America First policy in action. It is a long overdue first step towards tackling waste, rooting out fraud, and demanding accountability from institutions that benefit from federal safety-net programs.
Congress should not stand in the way. It should let the hospital transparency reform move forward without interference.